Patent Drawing in Amsterdam.

A patent drawing Amsterdam applicants commission has to work in a filing route that surprises people the first time they meet it: the Netherlands has no direct national phase from a PCT application. An Amsterdam company filing internationally reaches the Dutch market through the European regional phase at the EPO, then validates here — so the figures that matter are the ones the EPO will accept. Add a national route that grants without substantive examination, and a city whose filings skew to software, payments and medical technology rather than heavy engineering, and the brief looks nothing like one in Brainport Eindhoven. PerspireIP prepares figure sets for Amsterdam filers from $25 a sheet.

Why a patent drawing Amsterdam filing has no Dutch PCT national phase

This is the single most consequential fact about filing into the Netherlands, and it catches foreign applicants and first-time Dutch filers alike.

Most countries let you take a PCT application and enter the national phase directly at the national office. The Netherlands does not. Octrooicentrum Nederland closed the national route from the PCT, so a PCT application cannot be nationalised directly in the Netherlands. The route into the Dutch market runs through the European regional phase at the EPO, with the granted European patent then validated for the Netherlands.

What that means in practice for your figures:

• Build the set to EPO expectations from the start. There is no later opportunity to substitute a looser Dutch-national figure set, because there is no Dutch national phase to substitute it into.
• PCT Rule 11 is your floor, not your ceiling. Drawings that merely scrape past the international phase can still draw a formalities communication when the application enters the European phase.
• Direct Dutch national filing is a separate decision — a first filing at Octrooicentrum Nederland, not a PCT derivative. It is a real option, and it has its own character (see the next section).

The Dutch legislature has been consulting on a modernised patent system that would, among other things, open a direct PCT-to-Netherlands national entry. That reform is proposed, not in force. Plan today’s filings on the law as it currently stands, and treat the EPO route as the operative one.

Octrooicentrum Nederland grants without examining the merits

The Dutch national patent is a registration right. Octrooicentrum Nederland, part of the Netherlands Enterprise Agency (RVO), does not examine applications for novelty or inventive step. Provided the formal requirements are met, the patent is granted. A search report is prepared and published, but an unfavourable search result does not stop the grant.

Two consequences follow, and they pull in opposite directions.

1. Formalities are effectively the only pre-grant bar. There is no examiner arguing about claim scope who might also tidy up your figures along the way. Drawing defects that another office would catch and let you fix during a long prosecution simply travel into the granted patent here.
2. Validity is tested later, in court. Because the office did not vet the merits, the real examination happens in a revocation or infringement action — where your figures are read adversarially by opposing counsel looking for support problems and inconsistencies between the drawings and the description.

It is also worth knowing what no longer exists. The Netherlands used to offer a choice between a six-year and a twenty-year patent, with the six-year right granted without a mandatory novelty search. The six-year patent ceased to exist on 5 June 2008. Today the twenty-year patent is the only Dutch national patent, and the search report is mandatory.

That is why a patent drawing Amsterdam attorneys send to the national office deserves the same scrutiny as one destined for a fully examining office. Nobody downstream is going to catch a mislabelled reference sign for you. The sheets you file are, in substance, the sheets you are stuck with.

Flowcharts, GUIs and the Amsterdam software and payments stack

Amsterdam’s filing profile is not Eindhoven’s. The city’s patent activity is concentrated in payments and fintech, travel and marketplace platforms, navigation and mapping, adtech and media — companies such as Adyen, Booking.com and TomTom sit here, alongside a deep bench of scale-ups. These portfolios are dominated by computer-implemented inventions, and that changes what a figure set has to do.

Software figures carry specific risks that mechanical figures do not:

• A flowchart has to be a disclosure, not a summary. Boxes reading “process transaction” or “apply model” invite an objection that the drawings add nothing to the description. Each step should name the operation at the level of detail the claims rely on.
• System architecture diagrams need consistent reference signs. Every element in the figures must appear in the description with the same sign throughout — a requirement the EPO enforces strictly and one that is easy to break when a diagram is redrawn late in drafting.
• Screen displays are figures too. Interface states shown as screenshots need to be redrawn as clean line art for the utility case, with the display boundary and the claimed interface elements clearly distinguished.
• No shaded CAD renders. Gradient-shaded exports reproduce badly at publication scale and are not solid-line drawings in the sense the rules require.

Where the interface itself is the commercial asset, the utility figures are only half the job — the GUI design patent drawing conventions govern the rest, and they are not the same conventions.

There is a drafting habit worth breaking here. Software teams often treat the figures as an afterthought generated from an existing design document, which produces diagrams pitched at the wrong altitude — either a marketing block diagram with four boxes, or an engineering schematic carrying implementation detail the claims never mention. Neither supports the claims well. The figure set should track the claim structure: one view establishing the system context, one per independent claim showing that method as a sequence, and detail views for the steps the dependent claims turn on.

Philips, medtech and the figures a device filing needs

Amsterdam is also the headquarters city of Philips, and the medical technology supply chain around it generates a steady stream of device and diagnostics filings. These need a different kind of figure entirely.

Device disclosures live in the cross-section, and cross-sections bring hatching rules into play. Under the US standard at 37 CFR 1.84(h)(3), hatching must be regularly spaced oblique parallel lines, preferably at 45 degrees, and must not impede the clear reading of the reference characters — a real constraint when a multi-lumen catheter tip carries ten callouts in a few millimetres of printed figure.

Diagnostics filings raise a second question: whether a photograph is admissible at all. The US rule permits photographs where they are the only practicable medium, and expressly names subjects including histological tissue cross sections, cell cultures and in vivo imaging. The EPO is less permissive, so a European set normally needs line art even where the US set rests on imaging. We work through both regimes in our guide to patent drawings for medical devices.

Benelux and EU design rights for Amsterdam’s consumer brands

There is no national Dutch design registration. Design protection in the Netherlands is Benelux-wide, obtained from the Benelux Office for Intellectual Property (BOIP) in The Hague and covering the Netherlands, Belgium and Luxembourg as a single territory. The alternative is a registered EU design at the EUIPO, covering the whole single market.

For Amsterdam’s consumer, media and app businesses this is often the faster commercial right, because design registration is quick and does not require examination of novelty on the merits. The figures do almost all the work, since the representations define the scope of what you own.

Design representations follow their own discipline:

• Views must be consistent with one another and show a single design — mixed prototypes across views invite an objection or a narrowing.
• A plain, neutral background keeps environmental clutter out of the scope of protection.
• Disclaimers matter. Parts you do not claim should be visually separated from the parts you do, so the registration covers the feature you actually want to enforce.
• A screen interface can be registered as a design, which is frequently the quickest protection available for an Amsterdam fintech or marketplace product.

Where an Amsterdam patent dispute is actually heard

Not in Amsterdam. Dutch patent litigation is centralised: the District Court of The Hague (Rechtbank Den Haag) has exclusive jurisdiction over patent matters in the Netherlands, including validity, infringement and ownership, with appeals going to the Court of Appeal in The Hague (Gerechtshof Den Haag). An Amsterdam company sued on a Dutch patent litigates in The Hague regardless of where it is based.

Since the Unified Patent Court opened on 1 June 2023, that picture has a second layer. The Netherlands hosts a UPC local division in The Hague, which hears infringement and revocation actions on European patents that have not been opted out, with effect across the participating member states rather than the Netherlands alone.

The practical point for drawings is simple. The Hague bench is one of the most experienced patent judiciaries in Europe, and figures are read closely there — for claim construction, for added matter, and for whether the description genuinely supports what the drawings show. Inconsistency between a figure and the text is not a cosmetic problem at that level.

There is a tactical dimension too. The Hague is a popular venue for cross-border proceedings and for preliminary injunctions, which move quickly. In a fast interim hearing the court is working from the patent as filed, and a figure that is ambiguous, inconsistent with the description, or missing a feature the claim depends on is a weakness that opposing counsel will reach for first.

One figure set for the EPO, the PCT and the USPTO

Most Amsterdam portfolios run the EPO, the PCT and a US filing in parallel, so the economical approach is a single master set built to satisfy the strictest requirement in each dimension.

The three rule books, as they currently stand:

• PCT Rule 11 — the physical specification for international sheets: A4, margins of 2.5 cm top, 2.5 cm left, 1.5 cm right and 1.0 cm bottom, a usable surface no larger than 26.2 cm by 17.0 cm, durable black uniformly thick lines, and numerals at least 0.32 cm high.
• EPO — and here a widely-copied citation is now wrong. Rule 46 EPC, “Form of the drawings,” was deleted with effect from 1 February 2023. Presentation requirements for European application documents are now determined by the President of the EPO under Rule 49(2) EPC and restated in the EPO Guidelines, Part A, Chapter IX. A response that argues the text of Rule 46 is arguing from a rule that no longer exists.
• 37 CFR 1.84 — the US standard, which overlaps with PCT Rule 11 but is not identical to it, and which governs hatching, photographs and the colour petition.

Build to the intersection and you file one set everywhere. Build to whichever office you happen to be filing at first, and you pay for the redraw later — usually under deadline. Our breakdown of the PCT drawing requirements sets out the measurements in full.

How PerspireIP handles patent drawing Amsterdam work

We work the way Amsterdam portfolios are actually run — several routes open at once, deadlines set by the EPO rather than by a Dutch national phase, and a mix of software and device subject matter in the same company.

• One master set, three rule books. Every figure is built to satisfy PCT Rule 11, the current EPO presentation requirements and 37 CFR 1.84 together, so the same sheets carry through the international phase, the European regional phase and a US filing without a redraw.
• Reference-sign reconciliation. We cross-check every sign in the figures against the description and flag the mismatches before filing, which is the defect most likely to survive into a granted Dutch registration patent.
• Software and device competence in one place. Flowcharts, architecture diagrams and interface views for the fintech and platform work; sectional views, assemblies and exploded views for the medtech work.
• Design representations. Consistent view sets for a Benelux design at BOIP or a registered EU design at the EUIPO, with deliberate disclaimers so the scope matches what you intend to enforce.
• Formats your firm can use. Deliverables in PDF, TIFF, DOCX or editable vector source, so later amendments do not mean starting again.

Typical turnaround on patent drawing Amsterdam projects is three to five business days, with expedited delivery when a priority or regional-phase date is close. Pricing starts at $25 a sheet and we confirm the sheet count before any work begins, so the quote you approve is the invoice you receive.

IP Landscape & Resources in Amsterdam

Key intellectual-property authorities and venues relevant to Amsterdam:

• Octrooicentrum Nederland (RVO) — the Netherlands Patent Office, which grants national patents on a registration basis without examining the merits
• WIPO — PCT Rule 11 — the physical requirements every international drawing sheet must meet
• European Patent Office — the route through which PCT applications reach the Netherlands, and the source of current presentation requirements
• Benelux Office for Intellectual Property (BOIP) — the registry for Benelux designs, there being no national Dutch design right
• Unified Patent Court — the local division in The Hague, open since 1 June 2023

Get Patent Drawings for Your Amsterdam Filing

Explore related PerspireIP services: Patent Drawing services · PCT drawing requirements · patent drawings for medical devices · GUI design patent drawings · EPO colour patent drawings.

Frequently Asked Questions